SCHEMBL14743265

SCHEMBL14743265

COc1ccc(Cn2c(CCN)cc3cccc(Cl)c3c2=O)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 4/20 0.42
TP53 P04637 2/20 0.42
NPBWR1 P48145 1/20 0.41
MAPK1 P28482 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
LMNA P02545 1/20 0.41
PROKR2 Q8NFJ6 1/20 0.41
PROKR1 Q8TCW9 1/20 0.41
TAAR1 Q96RJ0 1/20 0.40
GRM2 Q14416 1/20 0.40
P2RX4 Q99571 1/20 0.40
PDE1B Q01064 1/20 0.40
DCTPP1 Q9H773 1/20 0.40
CLTC Q00610 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179604 0.80 CHRM5 (0.44) CHRM5KDM4EMAPTTP53NPBWR1
SCHEMBL14718403 0.80 CHRM5 (0.44) CHRM5KDM4EMAPTTP53NPBWR1
SCHEMBL25433242 0.75 KDM4E (0.48) CHRM5KDM4EMAPTTP53NPBWR1
SCHEMBL31208038 0.75 KDM4E (0.48) CHRM5KDM4EMAPTTP53NPBWR1
SCHEMBL18074889 0.74 PDE10A (0.50) CHRM5KDM4EMAPTNPBWR1NPSR1
SCHEMBL20081377 0.73 BRD4 (0.45) KDM4EMAPTMAPK1NPSR1LMNA
SCHEMBL14638047 0.73 MAPT (0.41) KDM4EMAPTMAPK1NPSR1
SCHEMBL2599468 0.72 PIK3CD (0.42) TAAR1
SCHEMBL25432242 0.70 KDM4E (0.44) KDM4EMAPTTP53LMNAP2RX4
SCHEMBL16584828 0.69 PIK3CD (0.42) MAPTTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751093-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2014-07-09 EP disclosed
WO-2013032591-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS INC. (US) 2013-03-07 WO disclosed